Page last updated: 2024-11-04

gatifloxacin and Liver Diseases

gatifloxacin has been researched along with Liver Diseases in 1 studies

Gatifloxacin: A fluoroquinolone antibacterial agent and DNA TOPOISOMERASE II inhibitor that is used as an ophthalmic solution for the treatment of BACTERIAL CONJUNCTIVITIS.
gatifloxacin : A monocarboxylic acid that is 4-oxo-1,4-dihydroquinoline-3-carboxylic acid which is substituted on the nitrogen by a cyclopropyl group and at positions 6, 7, and 8 by fluoro, 3-methylpiperazin-1-yl, and methoxy groups, respectively. Gatifloxacin is an antibiotic of the fourth-generation fluoroquinolone family, that like other members of that family, inhibits the bacterial topoisomerase type-II enzymes.

Liver Diseases: Pathological processes of the LIVER.

Research Excerpts

ExcerptRelevanceReference
" All treatment-emergent adverse events were mild or moderate in intensity and resolved before subjects were discharged from the study."1.31Safety and pharmacokinetics of a single oral dose of gatifloxacin in patients with moderate to severe hepatic impairment. ( Christofalo, B; Duncan, G; Grasela, DM; Kollia, GD; LaCreta, FP; Manning, JA; Noveck, R, 2000)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Grasela, DM1
Christofalo, B1
Kollia, GD1
Duncan, G1
Noveck, R1
Manning, JA1
LaCreta, FP1

Other Studies

1 other study available for gatifloxacin and Liver Diseases

ArticleYear
Safety and pharmacokinetics of a single oral dose of gatifloxacin in patients with moderate to severe hepatic impairment.
    Pharmacotherapy, 2000, Volume: 20, Issue:6 Pt 2

    Topics: Adult; Anti-Infective Agents; Area Under Curve; Case-Control Studies; Female; Fluoroquinolones; Gati

2000